AngioDynamics Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
AngioDynamics (ANGO) Misses Q4 EPS by 1c, Revenues Miss
July 11, 2018 7:02 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $88.3 million versus the consensus estimate of $89.32 million.
Fiscal 2018 Fourth Quarter Highlights
Net sales of $88.3 million, an increase of 1.6% year over yearGross margin expanded 500 basis points year over year to 53.7%GAAP EPS... More